Although progression to blast crisis CML was not observed, these data clearly indicated that expression of BCR-ABL resulted in deregulated growth and differentiation which in some cases progressed to early stage disease. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.